相关实验视频

Updated: Sep 18, 2025

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

修改脂质颗粒识别:动脉样硬化与癌症之间的联系?

Amy E Hall¹, Dhananjay Jade^1,2, Faheem Shaik^1,2

¹School of Molecular & Cellular Biology, University of Leeds, Leeds LS2 9JT, UK.

|June 26, 2025

概括

功能障碍的脂质代谢与动脉样硬化和癌症有关. 准LOX-1吸尘器受体可能为动脉疾病和前列腺癌,结肠直肠癌和肺癌等癌症提供新的治疗方法.

科学领域:

心血管研究的心血管研究.
在瘤学瘤学.
代谢性疾病是一种代谢性疾病.

背景情况:

心血管疾病和癌症是全球死亡的主要原因.
动脉样硬化是由脂质代谢功能障碍驱动的,有助于心脏病发作和中风.
新出现的证据表明动脉样硬化和癌症发展之间存在联系.

研究的目的:

审查新出现的证据,将动脉样硬化与癌症联系起来.
探索清除受体 (SRs),特别是LOX-1在调解这些链接中的作用.
讨论针对SR介导信号的治疗潜力.

主要方法:

文献综述侧重于脂质代谢,食尸体受体和信号通路的作用.
分析证据,将氧化脂质,SRs (特别是LOX-1) 与两种疾病中的细胞反应联系起来.
对NF-κB通路和LOX-1信号在动脉样硬化和癌症中的检查.

主要成果:

动脉样硬化中的修饰和氧化脂质激活拾尸体受体 (SRs),促进炎症和斑块进展.
通过SR介导的信号传递,特别是通过LOX-1,促进癌细胞的生长,增殖和转移.
洛克斯-1信号影响关键的细胞过程,包括细胞亡和上皮细胞-介质细胞过渡.
较高的LOX-1水平与心血管疾病和几种癌症的预后不佳相关.

结论:

类似于莱克的氧化低密度脂蛋白 (LOX-1) 拾取体受体在动脉样硬化和癌症中起着双重作用.
洛克斯-1信号通路与动脉疾病和恶性瘤的进展有关.
抑制LOX-1功能为管理这两种疾病提供了潜在的治疗策略.

关键词:

洛克斯-1号机场灭症 (apoptosis) 是一种死亡的过程.动脉样硬化动脉样硬化癌症癌症癌症癌症癌症这是一种炎症炎症炎症炎症.脂质颗粒是一种脂质颗粒.它们的扩散和扩散.拾尸体受体的受体拾尸体受体信号传导的信号传导.

更多相关视频

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on: January 31, 2025

Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis

Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis

Published on: November 17, 2017

相关概念视频

Atherosclerosis I: Introduction

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...

Inflammation

Inflammation

Receptor-mediated Endocytosis

Receptor-mediated Endocytosis

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Lipid-derived Compounds in the Human Body

Lipid-derived Compounds in the Human Body

Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...